semaglutide oral approval FDA Approves Semaglutide: First GLP-1 Weight Loss Pill FDA Approves First ORAL GLP-1
Description
Weight loss with Ozempic or Wegovy requires patients to inject themselves with the medication a reported drawback for some people
They aim to determine if patients who receive semaglutide at escalating doses over 9 weeks will consume less alcohol (the primary outcome) and smoke less (a secondary outcome) than those who receive a placebo
Splitting 12.5mg works well in practice
Laxatives are medicines for constipation
In short, it is the synthetic form of GLP-1
Some want support with recovery after exercise
